Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,736 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: work therapy Clear all

Conditions: Autism, Communication Disorders
Interventions: iPad Application; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 4 Years to 18 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Insomnia
Interventions: In-person Cognitive Behavioral Therapy of Insomnia, Internet Cognitive Behavioral Therapy of Insomnia; Behavioral
Lead sponsor: Daniel J. Taylor, Ph.D.; Other
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Fort Hood, Texas

Conditions: Delirium, Cognitive Decline, Dementia
Interventions: Cognitive Training, Goal Management Training; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Cognitive Decline, Cognitive Impairment
Interventions: TMS; Device
Lead sponsor: San Francisco Neurology and Sleep Center; Other
Eligibility: 50 Years to 90 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Small-cell Lung Cancer, Large Cell Neuroendocrine Carcinoma of the Lung, Extrapulmonary Small Cell Carcinoma
Interventions: Abemaciclib,; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Clinic-Based Cognitive Remediation, Partial-Remote Cognitive Remediation; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 30 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 9
States / cities: Brooklyn, New York • New York, New York • Queens, New York + 3 more

Conditions: Resistance Training, Colon Cancer, Chemotherapy Effect
Interventions: Resistance training; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Oakland, California • Boston, Massachusetts • Hershey, Pennsylvania

Conditions: Chronic Stroke
Interventions: Treatment; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Cancer, Early Stage Estrogen Receptor (ER) Positive Breast Cancer
Interventions: BCI Assay Results; Behavioral
Lead sponsor: Yale University; Other
Eligibility: Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: Memantine XR-pregabalin combination therapy; Drug
Lead sponsor: Saint John's Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Aphasia, Stroke
Interventions: Speech and Language Therapy; Behavioral
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: CNS Oxygen Toxicity, Ketogenic Diet
Interventions: Ketogenic Diet; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Metabolic Syndrome, Insulin Resistance, Prediabetes
Interventions: Pioglitazone; Drug
Lead sponsor: Philip Kern; Other
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 2
States / cities: Little Rock, Arkansas • Lexington, Kentucky

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Placebo, OROS-methylphenidate; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 6 Years to 12 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections, Substance Use Disorders, Mental Health Disorder, Addiction, Opioid Use, Drug Use
Interventions: Collaborative Care Model; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Concussion, Brain
Interventions: Osteopathic Manipulative Therapy, Standard of Care Concussion Treatment; Procedure
Lead sponsor: Matthew T. Mcelroy, DO; Other
Eligibility: Up to 24 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Spinal Cord Injuries
Interventions: Functional Electrical Stimulation rowing exercise; Other
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Opiate Use Disorder
Interventions: Addiction Pilot App behavior tracking; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Warrensville Heights, Ohio

Conditions: Breast Cancer Female
Interventions: Metacognitive Strategy Training (MCST), Inactive Control Group; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 20 Years to 75 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Melanoma
Interventions: encorafenib, nivolumab, ipilimumab, binimetinib; Drug
Lead sponsor: Jason J. Luke, MD; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Haemophilia A, Haemophilia B, Obesity
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 317 participants
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Plainsboro, New Jersey

Conditions: Substance Use Disorders
Interventions: Community Support Intervention Group, Substance Use Disorder Educational Group; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Advanced/Metastatic Colorectal Adenocarcinoma
Interventions: BAY 3771249, Cetuximab; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 7
States / cities: Phoenix, Arizona • Duarte, California • San Diego, California + 4 more

Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus
Interventions: Finerenone (Kerendia, BAY948862), Others except finerenone; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 238,038 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Whippany, New Jersey

Search by objective public record fields.

iPad Application to Treat Prosodic Deficits in Students With Communication Disorders

Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia

Early Cognitive Intervention in Delirium

Effects of Accelerated rTMS on Cognitive Function

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Cognitive Remediation for Coordinated Specialty Care

FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study

intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)

Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

Memantine XR and Pregabalin for Chemotherapy-Induced Peripheral Neuropathy

The Intensive Comprehensive Aphasia Program (ICAP)

Ketogenic Diet for Reduction of CNS Oxygen Toxicity in Working Divers

Mechanisms Underlying Metabolic Syndrome in Obesity

Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory

Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care

Reduction of Concussion Symptoms Through the Use of Osteopathic Manipulative Therapy

An Exercise Intervention to Reduce Neuropathic Pain and Brain Inflammation After Spinal Cord Injury

Application Based Addiction Treatment Adherence Trial

Cognitive Rehabilitation Following Breast Cancer Treatment

Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Activating Community Support for Substance Users

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States